Milestone Non Operating Income Net Other from 2010 to 2025
| MIST Stock | USD 1.96 0.08 3.92% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 198 K | Current Value 378.4 K | Quarterly Volatility 232.3 K |
Check Milestone Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.1 M or Interest Income of 4.4 M, as well as many indicators such as Price To Sales Ratio of 32.97, Dividend Yield of 0.0 or PTB Ratio of 11.73. Milestone financial statements analysis is a perfect complement when working with Milestone Pharmaceuticals Valuation or Volatility modules.
Milestone | Non Operating Income Net Other | Build AI portfolio with Milestone Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.